HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respons...
| 主要作者: | |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
AboutScience Srl
2018-06-01
|
| 叢編: | AboutOpen |
| 主題: | |
| 在線閱讀: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/160 |